Skip to content
AwardedSpainGoodsFramework agreement

ACUERDO MARCO DEL SUMINISTRO DE SOMATROPINA PARA EL SÍNDROME DE NOONAN

Published
Published 13 July 2026

Overview

The Consorci de Salut i d'Atenció Social de Catalunya has awarded a framework agreement for the supply of Somatropin for Noonan syndrome to NOVO NORDISK PHARMA, S.A. on 9 July 2026. The procurement is complete.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Contract type
Framework agreement
Published
13 July 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€0
Award date
9 July 2026
Winner
  • NOVO NORDISK PHARMA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    13 July 2026

Contracting authority

  • Consorci de Salut i d'Atenció Social de Catalunya

    Procuring entity

    No consta, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: ACUERDO MARCO DEL SUMINISTRO DE SOMATROPINA PARA EL SÍNDROME DE NOONAN — won by NOVO NORDISK PHARMA, S.A. — Skim